DNA GTx’s NIPT Plus analyzes fetal cell-free DNA (cfDNA) from maternal blood to screen for all autosomal aneuploidies (chromosomes 1–22), sex chromosome aneuploidies, and a broad range of common copy number variations (CNVs). This panel also provides accurate fetal sex determination. As the most comprehensive minimally invasive prenatal screening available, it enables early detection of a wide spectrum of genetic conditions, empowering expectant parents and healthcare providers with detailed information for informed prenatal care.
Offer the Most Comprehensive Prenatal Screening
With DNA GTx NIPT Plus, you can provide expectant parents with the widest genetic coverage available — screening all autosomal chromosomes, sex chromosome aneuploidies, common CNVs, and determining fetal sex
Gain Maximum Insight Into Your Baby’s Health
Safe from 10 weeks of pregnancy and with results ready in 7–10 days, NIPT Plus supports informed decisions, early care planning, and peace of mind for your pregnancy journey.
*All information is handled with strict confidentiality.